Sat.Jan 06, 2024 - Fri.Jan 12, 2024

article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. This article highlights the manifold applications of AI, particularly cutting-edge image recognition and computer vision systems, which profoundly impact quality control.

article thumbnail

As she drives research on structural racism in health care, Rachel Hardeman faces a painful reckoning

STAT

MINNEAPOLIS — It’s been almost four years since George Floyd was murdered here at 38th Street and Chicago Avenue, a South Minneapolis corner anchored by a convenience store, its red awning still achingly familiar from once-saturating news coverage. Now, the legions of teddy bears placed in Floyd’s honor are dusty, the paint on street murals has chipped away, and community-built planters are overgrown.

363
363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials

PharmaVoice

As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.

329
329
article thumbnail

Breaking: GP practices and PCNs now eligible for pharmacist training funding

The Pharmacist

General practices and primary care networks (PCNs) will be able to employ pharmacist trainees from 2025, making them eligible for the recently updated NHS England (NHSE) pharmacist training grant. While some general practice and PCN sites have already hosted pharmacist trainees for part of their placement, this has been administered under a memorandum of understanding […] The post Breaking: GP practices and PCNs now eligible for pharmacist training funding appeared first on The Pharmacist.

127
127
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

JPM: Four ways FDA is seeking to buoy gene therapy

pharmaphorum

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

134
134
article thumbnail

Opinion: Addressing the Black youth suicide crisis requires a new approach to licensing clinical social workers

STAT

In the spring of 2020, Jamal Clay , a gifted young man who grew up in the south suburbs of Chicago, died by suicide. He was 19 years old. Jamal’s loved ones describe him as creative and talented, a leader in different youth-focused organizations in his community who supported and cared for those he loved. He was just as brilliant as he was kind.

363
363

More Trending

article thumbnail

NHS App to enable barcode prescriptions later this month

The Pharmacist

A new NHS App functionality, going live 30 January, will allow patients to generate a prescription barcode to collect their medicines from any pharmacy. This will enable patients without a nominated pharmacy to take their prescription electronically to any pharmacy for collection without the need for a paper prescription. GPs already generate most prescriptions electronically […] The post NHS App to enable barcode prescriptions later this month appeared first on The Pharmacist.

120
120
article thumbnail

How Quantum Computing Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag

PharmExec

Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.

126
126
article thumbnail

Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry

STAT

Since having a baby 10 months ago, I’ve learned many things. Chief among them: Pumping sucks. But skipping a session ends up being even more painful. Naturally, I expected navigating the J.P. Morgan Healthcare Conference in San Francisco would be more complicated this year. Somehow, between back-to-back meetings and presentations, I’d have to bust out that abominable contraption and do my thing.

360
360
article thumbnail

Pharma execs sound off on trends and policies they’re tracking in 2024

PharmaVoice

From regulatory concerns to leadership skills, pharma leaders at JPM shared how they’re approaching the coming year.

196
196
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New MPharm course to be launched in Leicester

The Pharmacist

The University of Leicester has introduced a new Master of Pharmacy (MPharm) degree programme in a bid to tackle the UK’s pharmacist shortage. It has been provisionally accredited by the General Pharmaceutical Council (GPhC), and is open to applications for autumn 2024 entry, subject to final approval. The course will offer small group teaching alongside […] The post New MPharm course to be launched in Leicester appeared first on The Pharmacist.

121
121
article thumbnail

Novavax: Creating tomorrow’s vaccines today

pharmaphorum

Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.

Vaccines 122
article thumbnail

STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing. Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates.

360
360
article thumbnail

Regulatory twists and turns are coming for biopharma in 2024

PharmaVoice

New FDA requirements and the IRA will create complexity in the coming year. Here’s how the industry can navigate the changes.

190
190
article thumbnail

Make pharmacy an election topic, urges RPS

The Pharmacist

The Royal Pharmaceutical Society (RPS) has called on pharmacists to engage with their MPs to help ensure pharmacy is part of health service debates ahead of the next general election. It has developed a pledge, dubbed a ‘Pharmacy Manifesto’, asking MPs to sign a ‘prescription for the nation’s health’. If elected, these MPs would campaign […] The post Make pharmacy an election topic, urges RPS appeared first on The Pharmacist.

102
102
article thumbnail

Generative AI and its impact on speed to market for pharmaceuticals

pharmaphorum

Generative AI is revolutionising the pharmaceutical industry, accelerating the speed to market for new drugs. Learn how regulatory processes, R&D, and clinical trials are being impacted by this innovative technology.

115
115
article thumbnail

Nearly 1 in 10 teens globally have used ‘budget Ozempic’ laxatives and other risky weight loss products, per study

STAT

New weight loss medications like Ozempic and Wegovy have garnered a lot of attention in the past year, but they aren’t always easy to get, especially for young people. Instead, teens surfing TikTok often see other options that don’t even require a doctor’s note. Berberine, for example, is a supplement that has been referred to online as “nature’s Ozempic.

356
356
article thumbnail

Backed by billionaires, a new biomedical institute tests an unorthodox approach

BioPharma Dive

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

126
126
article thumbnail

Merck, Johnson & Johnson Announce Acquisitions to Bolster Respective Oncology Pipelines

PharmExec

Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.

115
115
article thumbnail

Research grants open for UK pharmacists and pharmacy technicians

The Pharmacist

A number of grants from Pharmacy Research UK (PRUK) are now open for application, including full funding for a full-time PhD studentship. The PhD Studentship Award is being trialled in PRUK’s annual funding round for the first time in place of its Research Development Awards. It is designed to support the salary, tuition and research […] The post Research grants open for UK pharmacists and pharmacy technicians appeared first on The Pharmacist.

article thumbnail

The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

STAT

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home th

357
357
article thumbnail

5 changes underway for R&D IT shifting to advanced modalities and biologics

pharmaphorum

The FDA is overseeing significant changes in R&D IT as it shifts towards advanced modalities and biologics. This includes the emergence of CRISPR-Cas9 gene editing technology and its potential impact on diseases like sickle cell anaemia. Learn more about these exciting developments in this article.

112
112
article thumbnail

New NHC Project Looking at Chronic Kidney Disease Disparities

Putting Patients First Blog

New NHC Project Looking at Chronic Kidney Disease Disparities January 11, 2024 By: Lillian Q. Witting, MPH, CAMP, NHC Coordinator, Research, Education & Programs With the start of the new year, the National Health Council (NHC) will be partnering with the American Kidney Fund (AKF) to comprehensively capture the patient experience of those living with chronic kidney disease (CKD), utilizing its evidence-based Patient Experience Mapping toolbox (PEMT).

article thumbnail

Sector surveyed on Pharmacy First readiness

The Pharmacist

Contractors, employed and locum pharmacists are being asked whether they feel ready to launch Pharmacy First at the end of this month. Community Pharmacy England (CPE) has released a survey asking contractors about their opinions about the service. Meanwhile the Pharmacists’ Defence Association has also released its own survey assessing the feelings of employed and […] The post Sector surveyed on Pharmacy First readiness appeared first on The Pharmacist.

article thumbnail

Opinion: Americans are obsessed with health and fitness tracking. It’s time for a data diet

STAT

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

357
357
article thumbnail

JP Morgan Week 2024 - Day 2

pharmaphorum

On Day 2 of the JP Morgan 2024 conference, there are exciting presentations from companies such as Daiichi-Sankyo, Recode Therapeutics, and Vir Biotech. The focus was on innovative advancements in healthcare and the contributions of women in the industry. Learn more about the highlights of this day.

111
111
article thumbnail

Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

Drug Patent Watch

The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the… The post Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals appeared first on DrugPatentWatch - Make Better Decisions.

111
111
article thumbnail

Pharmacy IT systems to automatically update GPs from February

The Pharmacist

Community pharmacy IT systems will automatically send details of patient consultations to general practice clinical IT systems from February 2024 to facilitate the Pharmacy First service in England, NHS England (NHSE) has confirmed today. A GP will then check and update the patient’s record – replacing the current need for general practice staff to transcribe […] The post Pharmacy IT systems to automatically update GPs from February appeared first on The Pharmacist.

article thumbnail

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

STAT

Amid ongoing concerns over conflicts of interest, a new study found that 60% of the physicians who served as panel and task force members for the American Psychiatric Association’s official manual of psychiatric disorders received payments from industry totaling more than $14 million. And the authors argue the findings raise questions about the editorial independence of the reference book.

article thumbnail

Data-driven disease research harnessing the genome

pharmaphorum

Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.

110
110
article thumbnail

NPR on how low Drug Prices can Shortages

Drug Patent Watch

A recent story by NPR echoes the findings of a collaboration between DrugPatentWatch and Bloomberg, which examined increasing competition between generic drug makers. The NPR article discusses the challenges in… The post NPR on how low Drug Prices can Shortages appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Medicines warehouse workers strike over union recognition

The Pharmacist

Staff at a medical warehouse which works with major community pharmacy suppliers have today begun industrial action over trade union recognition issues. Members of the union Unite at Movianto in Bedford, which offers temperature-controlled warehousing to pharmaceutical supply chains including Alliance Healthcare UK and Phoenix, are staging a walkout which is set to last until […] The post Medicines warehouse workers strike over union recognition appeared first on The Pharmacist.

article thumbnail

STAT+: Nvidia says a biological revolution is happening now. But is it?

STAT

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear. The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P.

345
345
article thumbnail

This week in clinical trials: 2nd-5th January 2024

pharmaphorum

Stay up to date with the latest developments in clinical trials, including updates on Vicore, Mundipharma, Agios, Ultragenyx, EG 427, Orion, and MSD. Find out what these companies are working on and their potential impact on healthcare.

109
109
article thumbnail

JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform

BioPharma Dive

Albert Bourla acknowledged Pfizer’s difficult 2023, while a biotech CEO spoke with BioPharma Dive about building neuroscience startups.

122
122